SEC Form 3 · accession 0001213900-26-081408
Niki BioSolutions, Inc. · NIKI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kira Sheinerman
Director · 10% Owner
Period of report
Jul 20, 2026
Accepted (ET)
Jul 24, 2026 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001734005
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 1,515,293 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
1,515,016 shares are held directly by the Reporting Person and 277 shares are held in a joint brokerage account, over which the Reporting Person may be deemed to share voting and dispositive power.